Results 11 to 20 of about 276,970 (298)

Paraneoplastic thrombocytosis in ovarian cancer [PDF]

open access: yes, 2012
<p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Akl EA   +35 more
core   +1 more source

Epithelial Ovarian Cancer

open access: yes, 2021
Epithelial ovarian cancer is characterised by multiple histological subtypes and molecular diversity. Recent evidence indicates that most serous ovarian cancers originate from malignant tubal epithelium, while endometrioid and clear cell ovarian cancers develop most likely from endometriosis.
Olusegun Kayode Ajenifuja, Kunle Odunsi
openaire   +4 more sources

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer [PDF]

open access: yes, 2015
Epithelial ovarian cancer is often considered a single pathological entity, but increasing evidence suggests that it is rather a group of different neoplasms, each with unique pathological characteristics, molecular features, and clinical behaviours ...
Biglia, Nicoletta   +6 more
core   +3 more sources

Association of a common variant of gene with increased risk of serous epithelial ovarian cancer

open access: yesTumor Biology, 2017
In China, the majority of ovarian cancer patients (80%–90%) are women who are diagnosed with epithelial ovarian cancer. The SYNPO2 gene has recently been reported to be associated with epithelial ovarian cancer in Europeans.
Li Ma   +9 more
doaj   +1 more source

Inflammatory Cytokine Tumor Necrosis Factor α Confers Precancerous Phenotype in an Organoid Model of Normal Human Ovarian Surface Epithelial Cells

open access: yesNeoplasia: An International Journal for Oncology Research, 2009
In this study, we established an in vitro organoid model of normal human ovarian surface epithelial (HOSE) cells. The spheroids of these normal HOSE cells resembled epithelial inclusion cysts in human ovarian cortex, which are the cells of origin of ...
Joseph Kwong   +7 more
doaj   +1 more source

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer [PDF]

open access: yes, 2016
Introduction: In developed countries, ovarian cancer is the fourth most common cancer in women. Due to the nonspecific symptomatology associated with the disease many patients with ovarian cancer are diagnosed late, which leads to significantly poorer ...
A Hayashi   +130 more
core   +1 more source

The Challenges and Opportunities of lncRNAs in Ovarian Cancer Research and Clinical Use [PDF]

open access: yes, 2020
[Abstract] Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor.
Barreiro-Alonso, Aida   +6 more
core   +1 more source

Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer

open access: yesAnnals of Oncology, 2016
Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian cancer possess very limited clinical relevance highlighting the emerging need for identification of novel prognostic biomarkers as ...
Krzystyniak J.   +3 more
openaire   +3 more sources

Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value

open access: yesBIO Web of Conferences, 2017
Objective: To investigate the expression of matrix metalloproteinase-9 (MMP-9) and nuclear factor κappa-B (NF-κB) in different ovarian tissue and explore the relationship between their expression and clinicopathological features of epithelial ovarian ...
Wei Shen, Juan Chen, Xiurong Li, Jie Yin
doaj   +1 more source

Role of EZH2 in epithelial ovarian cancer: from biological insights to therapeutic target

open access: yesFrontiers in Oncology, 2013
EZH2 is the catalytic subunit of polycomb repressive complex 2 (PRC2), which generates a methylation epigenetic mark at lysine-27 residue of histone H3 (H3K27me3) to silence gene expression.
Hua eLi, Rugang eZhang
doaj   +1 more source

Home - About - Disclaimer - Privacy